Subjects: Nursing >> Nursing submitted time 2023-05-12
Abstract： Combination of peginterferon-alpha (PEG-IFN) and ribavirin (RBV) therapy is the current standard of care for chronic hepatitis C. This paper reviewed the studies of drug-related adverse reactions in hepatitis C patients who received PEG-IFN and RBV therapy, in order to increase awareness of medical staff and patients on drug-related adverse reactions, and provide reference for implementation of comprehensive interventions.
Peer Review Status:
Awaiting Review
Hits
Hits
Downloads
Comment